The release of placental-derived antiangiogenic factors (such as sFlt-1) into the maternal circulation can cause an imbalance in angiogenic factors (VEGF and PLGF), thus leading to endothelial dysfunction and PE symptoms (Cindrova-Davies, 2014). This evidence concerns the gene VEGFA and endothelial dysfunction.